Skip to Content
s - Skip to Content
0 - Access key details
1 - Back to top
2 - Header search

Tag: Prescription Drugs

Medicaid Expansion’s Impact on Prescription Drug Access

This edition examines the impact of Medicaid Expansion on prescription drug access, comparing prescription volume trends in 18 states that expanded Medicaid in 2014 with six non-expansion states. We look at overall prescription volume as well as three specific therapeutic…
Download 5 slide
KEYWORDS:, ,

Assessment of the Pharmacy Carve-In Model for Virginia’s Medicaid Program

This report explores the fiscal and programmatic impacts that a switch to a prescription drug carve-out model, where the pharmacy benefit would be managed under a single-payer system within Medicaid using the fee-for-service payment methodology, would have on Virginia’s Medicaid…
Download Full Report
ADDITIONAL RESOURCES:
KEYWORDS:,

Assessment of Washington State’s Medicaid Prescription Drug Management Performance and Policy Options

This report explores which prescription drug model is best suited for Washington’s Apple Health (Medicaid) program: the current carve-in prescription drug model, under which managed care organizations (MCOs) pay for members’ prescriptions, or a carve out model, where prescriptions are…
Download Full Report
KEYWORDS:, , ,

Medicaid MCO Innovations to Address the Opioid Epidemic

This edition provides excerpts of opioid-related questions that have appeared in Medicaid MCO procurements. These slides demonstrate some of the ways in which states are using their request for proposal (RFP) process to promote innovation and elevate the MCOs’ mechanisms…
Download 5 slide
KEYWORDS:, ,

Quantifying the Impact of State-Level Policy Changes on Opioid Prescription (and Unit) Volume ​

This edition looks at various state-level policy changes seeking to restrict inappropriate use of opioids, conducting a pre-versus-post comparison of prescription opioid usage related to the dates of these policy changes.
Download 5 slide
KEYWORDS:, ,

Trends in the Use of Prescription Opioids and MAT in the Medicaid Program  ​

This edition focuses on the trends in Medicaid prescription opioid and MAT use.  An example of our findings is that opioid prescriptions per Medicaid enrollee decreased 54% from 2013-2022.
Download 5 slide
KEYWORDS:,

Medicaid Prescription Drug Trends

This edition summarizes our tabulations of several key Medicaid prescription drug cost and usage trends across the 2018-2022 timeframe. Our findings include: • Pre-rebate costs per Medicaid prescription grew sharply, at an average annual rate of 9.7% from 2018-2022. •…
Download 5 slide
KEYWORDS:, ,
Back to top